tiprankstipranks
BioNTech SE (BNTX)
NASDAQ:BNTX
US Market

BioNTech SE (BNTX) Income Statement

Compare
4,492 Followers

BioNTech SE Income Statement

Last quarter (Q4 2024), BioNTech SE's total revenue was €1.19B, a decrease of -19.54% from the same quarter last year. In Q4, BioNTech SE's net income was €259.50M. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 2.75B€ 3.82B€ 17.31B€ 18.98B€ 482.32M
Gross Profit
€ 2.21B€ 3.22B€ 12.78B€ 15.12B€ -222.04M
Operating Expenses
€ 3.52B€ 2.53B€ 135.90M€ 200.10M€ -139.62M
Depreciation and Amortization
€ 298.00M€ 183.40M€ 121.08M€ 78.20M€ 36.10M
EBITDA
€ -367.10M€ 1.09B€ 12.43B€ 15.00B€ -105.10M
Operating Income
€ -1.31B€ 690.40M€ 12.64B€ 15.28B€ -82.42M
Other Income/Expenses
€ 636.60M€ 495.70M€ 311.40M€ -237.40M€ -63.40M
Pretax Income
€ -677.70M€ 1.19B€ 12.95B€ 15.05B€ -145.80M
Net Income
€ -665.30M€ 930.30M€ 9.43B€ 10.29B€ 15.20M
Per Share Metrics
Basic EPS
€ -2.78€ 3.83€ 38.08€ 43.87€ 0.06
Diluted EPS
€ -2.72€ 3.83€ 37.09€ 41.21€ 0.06
Weighted Average Shares Outstanding
239.74M 242.90M 243.30M 244.00M 235.44M
Weighted Average Shares Outstanding (Diluted)
244.57M 242.70M 249.80M 259.70M 248.53M
Currency in EUR

BioNTech SE Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis